FOXM1 and chronic myelogenous leukemia, BCR-ABL1 positive: We found that miR-370, which directly targets FoxM1, could sensitize K562 cells to HHT by inducing cell apoptosis, which may give hope for miRNA-based CML therapy with less drug toxicity.